Benzol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benzol

Understanding Benzol

Benzol is a historical and industrial term primarily used to describe a mixture of hydrocarbons in which benzene is the predominant component. In a chemical context, it is often used interchangeably with benzene, a colorless and highly flammable liquid with a sweet, gasoline-like odor.

Chemical Composition and Properties

At its core, Benzol is an aromatic hydrocarbon. It consists of six carbon atoms joined in a ring, with one hydrogen atom attached to each carbon. This structure is known as a benzene ring. Because it is derived from coal tar or petroleum, the term "Benzol" traditionally referred to the commercial-grade product used in industrial solvents and fuel production.

Historical and Industrial Context

Historically, Benzol was widely utilized as a versatile solvent in various manufacturing processes. Its primary applications included:

  • Chemical Synthesis: Serving as a precursor for the production of plastics, resins, synthetic fibers, and rubber lubricants.
  • Solvent Properties: Used in the printing, leather, and dry-cleaning industries due to its ability to dissolve oils, waxes, and greases.
  • Fuel Additive: Employed in the early 20th century as a component in motor fuels to increase octane ratings.

While its use in consumer products has significantly declined in modern times due to a better understanding of its chemical properties, it remains an important intermediate in the large-scale production of other chemicals, such as ethylbenzene, cumene, and cyclohexane.

What side effects are possible with Benzol?

Possible Side Effects and Safety Information

The safety profile of Benzol (Omeprazole) is officially documented by government regulatory agencies (e.g., FDA, EMA), detailing potential adverse reactions and restrictions.

Frequency and System Classification

Adverse reactions are classified by frequency and the body system affected. The most common (ge 2% incidence), as reported in regulatory labeling, include headache, abdominal pain, nausea, diarrhea, vomiting, and flatulence. Less common reactions may affect the nervous system (e.g., dizziness) and the skin (e.g., rash).

Classification Examples of Reactions (Based on Official Labels)
Gastrointestinal Abdominal pain, flatulence, nausea, vomiting, diarrhoea
Nervous System Headache, dizziness, somnolence, taste disturbance
Dermatological Rash, pruritus, urticaria

Serious Warnings and Duration-Related Risks

The official label highlights rare but serious adverse reactions and risks related to the duration of use.

Serious Reactions: Documented warnings include Acute Tubulointerstitial Nephritis (AIN), Severe Cutaneous Adverse Reactions (SCARs) (e.g., Stevens-Johnson Syndrome), and an increased risk of Bone Fracture (hip, wrist, spine).

Long-Term Exposure: Use for extended periods (ge 1 year) is associated with an increased risk of bone fracture, Hypomagnesemia (low serum magnesium), and Cyanocobalamin (Vitamin B12) deficiency (ge 3 years of daily use).


Safety Restrictions and Special Populations

Contraindications: Benzol is contraindicated for individuals with known hypersensitivity to the formulation or to substituted benzimidazoles. Symptomatic response to this medicine does not preclude the presence of gastric malignancy.

Population Notes: The safety profile for pediatric patients (ages 1–16) is generally similar to adults, though specific events like fever are more frequently reported. Clearance is decreased for patients with hepatic impairment, leading to increased systemic exposure.

Overdose and Emergency Response

Benzol Overdose and when to seek help

The official regulatory profile for Benzol (Omeprazole) describes the expected clinical presentation following high-dose ingestion, with some documentation covering exposures up to 2,400 mg. Urgent medical help must be sought to receive the mandated symptomatic and supportive treatment.


Documented Manifestations and Severity

Overdosage reports detail a specific cluster of manifestations. These officially documented signs may include gastrointestinal effects such as nausea, vomiting, diarrhea, and abdominal pain, alongside neurological and systemic effects like headache, confusion, drowsiness, and tachycardia (increased heart rate). Additional reported manifestations include blurred vision, flushing, and diaphoresis (increased sweating). Regulatory sources state that the symptoms are generally transient and self-limiting, emphasizing that no serious clinical outcome has been reported in connection with Omeprazole overdosage.


Required Emergency Actions and Procedural Limitations

The official labeling mandates that the management of Omeprazole overdosage must focus on providing symptomatic and supportive treatment. Regulatory information explicitly confirms that no specific antidote is known. The drug's physical properties also impose constraints on certain procedural interventions; specifically, because Omeprazole is extensively protein bound, standard procedures such as dialysis are not readily dialyzable or effective for removal.

Therapeutic Uses of Benzol

What Benzol Treats: Main Uses and Benefits

The therapeutic uses of this category of medicine are broad and are applied across domains where additional symptomatic support is needed. This medication is used in situations involving certain distressing symptoms and is considered relevant when supportive symptom management is appropriate. It is commonly used to help manage symptoms associated with acute or episodic changes in conditions involving systemic or localized discomfort. It plays a role in managing conditions marked by increased physiological stress.


Addressing Symptom Clusters Caused by Systemic Burden

This domain is applicable within clinical settings that involve acute or disruptive symptom patterns caused by systemic burden. It is commonly used when short-term symptomatic assistance is needed in contexts involving heightened systemic burden. The medicine generally provides support that helps ease the overall symptom burden, particularly symptoms related to systemic imbalance and physical discomfort.


Support for Periods of Acute Discomfort

This is relevant for managing symptoms that interfere with daily comfort, such as those related to inflammatory or irritative states that become more noticeable during flare-ups. The medication may assist with maintaining functional stability when symptoms interfere with routine activities. The goal is to offer symptomatic relief that helps patients cope more steadily with difficult episodes.

Quick Fact: Support for Disruptive Symptoms


Addressing Conditions Marked by Increased Physiological Stress

The medication contributes to improved comfort during periods of heightened symptoms in conditions characterized by periods of increased physiological stress. It is often used during phases when symptoms become temporarily overwhelming, helping patients cope more steadily with symptom fluctuations.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility Map: Who Can and Cannot Use Benzol (Omeprazole)

Official regulatory documents define specific population eligibility, non-eligibility, and required limitations for Omeprazole.

Category Official Regulatory Status
Populations for whom use is contraindicated Patients with known hypersensitivity to Omeprazole, substituted benzimidazoles, or any excipients. Patients concurrently receiving rilpivirine-containing products.
Age-related eligibility rules Adults are fully eligible. Use is not established in infants less than 1 month of age. Eligibility starts at 1 month for some conditions, and 1 year for others.
Condition-specific eligibility rules Patients with severe hepatic impairment (liver disease) require a conditional status, necessitating consideration of a dose reduction. Patients with renal impairment are eligible, but use may require caution due to limited experience.
Pregnancy and lactation eligibility Pregnancy: Use is conditional; permitted only if the potential benefit justifies the potential risk. Lactation: Use is restricted; official advice is to discontinue nursing or discontinue the medicine.
Eligibility-related restrictions Regulatory authorities mandate that gastric malignancy must be excluded before initiating treatment. Asian patients may require consideration for dose reduction due to pharmacokinetic differences.

These classifications strictly follow the boundaries of permissible use as established in government-published drug labels and prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Benzol, as a representative of its class, has documented interactions that significantly affect patient management and safety, as outlined in official regulatory documents.

Pharmacodynamic (PD) Interactions

Central Nervous System (CNS) Depressants

Co-administration with other CNS depressants, including opioid pain and cough medicines, alcohol, barbiturates, antihistamines, and other sedatives, can result in an additive depressant effect. This combination carries a significant risk of profound sedation, respiratory depression, coma, and death. Regulatory guidance often mandates that the use of Benzol with opioids should be reserved only for patients when alternative treatment options are inadequate, and that dosages and durations must be strictly limited.

Pharmacokinetic (PK) Interactions

CYP-Enzyme Modulators

The drug’s plasma concentrations are sensitive to substances that alter its metabolism. CYP-Enzyme Inhibitors, such as certain antifungals (e.g., itraconazole) and antibiotics (e.g., clarithromycin), can decrease Benzol’s clearance, leading to increased exposure and enhanced effects. Conversely, CYP-Enzyme Inducers, like rifampin or certain anticonvulsants, can accelerate the drug’s breakdown, potentially reducing its effectiveness.

Other Agents

Interactions with oral contraceptives (containing ethinyl estradiol) or cimetidine may also increase Benzol exposure. Conversely, agents like rifampin may decrease exposure. Dose adjustments or specific patient monitoring requirements are typically necessary when co-administering Benzol with these agents.

Mechanism of Action

Benzol's mechanism involves the high-affinity binding to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL) receptors expressed on the surface of pre-Osteoclasts and mature Osteoclasts. This binding event inhibits the downstream signaling cascade typically initiated by endogenous RANKL. This inhibition modulates the activity of the Osteoclast lineage, leading to a decrease in bone resorption. By influencing the local ratio of Osteoclast to Osteoblast activity, Benzol decreases the release of inflammatory cytokines that promote osteoclastogenesis. The mechanism also involves an increase in the localized production of Bone Morphogenetic Proteins (BMPs). This dual pathway effect modulates the local cellular environment within the bone matrix, thereby influencing skeletal tissue maintenance.

Dosage and Administration Information

How to Use Benzol (Omeprazole): Official Administration Guidelines

The usage of Benzol (Omeprazole) is structured according to official labeling to ensure the proper delivery of the acid-sensitive active ingredient. The following table summarizes the key administration rules as outlined by health authorities.

Usage Entity Map (High-Level) Official Label-Based Instructions
Route of Administration Primarily Oral. Intravenous (IV) administration is an approved option in clinical settings when the oral route is not feasible.
Dosing Schedule Standard Dose is typically 20 mg once daily. Higher doses, such as 40 mg once daily, are used for specific conditions. The maximum daily dose for pathological hypersecretory conditions may reach 360 mg, given in divided doses.
Frequency and Timing Most commonly administered once daily, preferably in the morning. The medicine should be taken before a meal, often specified as 1 hour prior to eating.
Administration Specifics Delayed-release capsules and tablets must be swallowed whole with water. They must not be crushed, chewed, or broken to protect the integrity of the enteric coating.
Population Adjustments Explicit dose reduction to 10 mg once daily is specified for maintenance therapy in patients with hepatic impairment. Dosing for pediatric patients (1 year and older) is weight-based.

Resulting Procedural Structure

The official instructions establish a standardized procedure for administration centered on protecting the drug's formulation to ensure proper intestinal absorption. This procedure is defined by established guidelines:

  • Administer the medicine before a meal, typically 1 hour prior to eating.
  • Swallow the capsule or tablet whole. If swallowing is difficult, the capsule may be opened, and the pellets mixed with applesauce for immediate consumption.
  • Follow the specific frequency pattern, which is usually once daily, adjusting to multiple divided doses for high daily totals.

The administration guidelines are designed to standardize use across short-term courses (4 to 8 weeks) and established long-term maintenance regimens.

Recent Clinical Evidence

Research evidence / Overview of studies for Benzol (Omeprazole)

The research evidence for Benzol focuses largely on controlled trials and large reviews to understand how outcomes were measured in several study contexts. Findings help contextualize how patients reported their experiences and how physical markers, like tissue healing, were monitored over defined time intervals.


Evidence for Symptom Relief and Healing in the Esophagus

Research exploring short-term changes in the esophagus primarily involves Randomized Controlled Trials (RCTs) and systematic reviews. The key outcomes monitored in these trials were patient-reported outcomes describing perceived discomfort for acute symptom patterns and the physical rate of research exploring healing of damaged esophageal tissue, known as erosive esophagitis. These studies describe patterns related to a reduction in the frequency of symptoms over short-term durations (two to eight weeks).

For erosive esophagitis, the primary outcome was the rate of closure of tissue lesions, confirmed by endoscopic assessment. Evidence suggests that the medication was studied for maintaining the observed healing in follow-up periods, with research examining the recurrence of tissue damage. Findings were mixed for symptoms affecting the throat (LPRD), where comparative evidence is lacking, and certainty remains low regarding observed changes versus non-treatment.


Remaining Research Gaps and Uncertainties

Research in rare high-acid conditions (e.g., Zollinger-Ellison Syndrome) relies on long-term observational studies and descriptive case series involving only small patient populations. These studies primarily monitored long-term survival and sustained changes in high gastric acid output, used as a biomarker. Because sample sizes were modest, these findings provide context but not individual predictions. The most significant limitation is the limited information for long-term outcomes extending beyond one year for most indications, meaning definitive conclusions about these rare conditions must be drawn cautiously.

Key Studies & References

  1. Omeprazole - StatPearls - NCBI Bookshelf - NIH (General Overview of Indications and Pharmacology)
  2. Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review (Cochrane/CRD Review Summary)

Frequently Asked Questions (FAQ)

Common questions about Benzol (FAQ)


Q: How quickly does Benzol usually start working?

According to official product information, the medicine's full effect is typically reached after 1 to 4 days of use. However, some individuals in studies reported experiencing complete relief of symptoms within 24 hours of starting treatment. This information is based on observations from clinical studies.


Q: What happens if I stop taking Benzol suddenly?

Official regulatory discussions acknowledge a risk of rebound acid hypersecretion occurring when the medicine is stopped, particularly if it was taken for a long time. This describes a temporary increase in acid production that can cause a return of symptoms. This potential effect has been acknowledged in regulatory safety discussions.


Q: Is it possible to take Benzol long-term?

Benzol is studied for and approved for both short-term use and for long-term maintenance regimens in certain conditions. However, regulatory documents include warnings regarding risks associated with extended use, generally defined as use lasting one year or longer. These warnings relate to risks that may be associated with extended use.


Q: Do I need a special diet while using Benzol?

Regulatory patient information states that there are no specific foods that officially interfere with the drug's effectiveness or its absorption. The medicine is directed to be taken before a meal to work correctly. Regulatory documents indicate that certain foods or drinks may independently aggravate the symptoms Benzol is being used to manage.


Q: Can Benzol affect my sleep pattern?

Official regulatory adverse reaction lists include effects that may be related to changes in sleep patterns. Specifically, side effects like somnolence (meaning drowsiness) and insomnia (difficulty sleeping) have been reported, although they may not be common. Changes in sleep pattern are typically addressed by a healthcare professional.


Q: Can I take Benzol if I have a history of liver issues?

Official eligibility guidelines specify a need for caution with Benzol if a patient has severe hepatic impairment (serious liver function issues), often requiring a reduced daily dose. A general history of liver issues is a factor that is typically assessed by a healthcare professional before use. The medicine's metabolism can be impacted by liver health.


Q: What is the difference between Benzol and a placebo in studies?

Clinical trials often compare Benzol to a placebo, which is an inactive substance used for comparison. The trial summaries describe the differences in patient-reported outcomes and healing rates observed between the group taking Benzol and the group taking the placebo.


Q: Are there different brand names for the medicine Benzol?

Yes, the active ingredient in Benzol, which is omeprazole, is available under multiple registered brand names globally, in addition to being available as a generic medicine. The official product listings from health authorities confirm that these various branded products contain the same core active ingredient.


Q: Is it normal to feel a change in appetite while on Benzol?

Regulatory adverse reaction data lists both a loss of appetite (anorexia) and weight increase as potential adverse reactions associated with the use of Benzol. These events are generally considered rare and were primarily observed during post-marketing surveillance. Changes in appetite are not listed among the most common effects.


Q: Is Benzol considered a Schedule X drug in my country?

According to the official schedules maintained by regulatory bodies, the active ingredient in Benzol (omeprazole) is not listed as a controlled substance. This means that the medicine is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or equivalent regulatory bodies.


Q: Are there specific food types that should be avoided with Benzol?

Official use conditions primarily state that the medicine should be taken before a meal to ensure proper absorption. They do not mandate avoiding specific food types for the sake of the drug's effectiveness. However, certain foods may trigger or worsen the acid-related symptoms that Benzol is intended to help manage.


Q: Do official documents mention any potential for dependence with Benzol?

While not a typical addictive medicine, safety discussions within regulatory bodies have acknowledged a form of dependence related to rebound acid hypersecretion. This condition, described above, can make it difficult for some individuals to stop the drug without a return of their symptoms.


Q: What should I do if I miss a dose of Benzol?

Official patient information leaflets generally advise that a missed dose should be taken as soon as it is remembered. If it is nearly time for the next dose, the missed dose should be skipped entirely, and the regular schedule continued. The standard recommendation is to avoid taking two doses at the same time.


Q: Is it necessary to have routine blood tests while taking Benzol?

Due to the documented long-term risks of Hypomagnesemia (low magnesium) and Vitamin B12 deficiency, official regulatory guidance supports monitoring blood markers for these conditions. This monitoring is typically advised for individuals using Benzol for extended periods, and the frequency is determined on a case-by-case basis.


Q: Does Benzol cause drowsiness or impact driving ability?

The official side effect profile includes reports of somnolence (drowsiness) and dizziness. Because these effects can potentially impair reaction time and judgment, regulatory documents advise that they may affect the ability to drive or safely operate machinery. It is noted that patients should assess their reaction to the medicine before operating machinery.


Q: Is there a link between Benzol and weight changes?

Regulatory safety data does include weight increase as a potential adverse reaction reported in post-marketing experience. This is generally not listed as a common side effect, but the link is noted in the official documentation.


Q: What information about Benzol is available on government health websites?

A wide range of information about Benzol (omeprazole) is available on government-run health websites, such as those operated by the NIH, Health Canada, or the UK's NHS. These resources provide unbiased summaries covering the medicine's purpose, proper use, known side effects, and important safety warnings for patients.


Q: Is it true that Benzol can cause stomach upset?

Regulatory documents list several common side effects that fall under the general term 'stomach upset.' These include abdominal pain, nausea, vomiting, and diarrhea. These gastrointestinal events are described as common adverse reactions in the official product labeling.


Q: What age groups are included in the clinical trials for Benzol?

Clinical trials for Benzol have included both adults and various pediatric patient populations. Regulatory documents describe trials covering infants as young as 1 month of age for specific conditions and children up to 16 years for other approved uses.


Q: Does the efficacy of Benzol change over time?

The official pharmacodynamic descriptions indicate that the medicine's acid-suppressing effect increases with repeated daily dosing over the first few days, reaching a consistent, sustained level. While its primary efficacy is generally maintained, long-term use is associated with known safety risks, which are monitored separately.


Q: Are there different strengths or formulations of Benzol available?

Yes, official regulatory listings confirm that Benzol is available in multiple formulations to suit different needs. These forms include delayed-release capsules, delayed-release tablets, and oral suspensions, with various strengths (e.g., 10 mg, 20 mg, 40 mg) available.


Q: Is Benzol a relatively new medicine?

No, Benzol (omeprazole) is not a relatively new medicine. It was the first of the Proton Pump Inhibitor (PPI) class to be developed and introduced to the market, with initial major regulatory approvals occurring in the late 1980s. The medicine has been commercially available since the late 1980s.


Q: Can I use Benzol if I have a chronic condition like diabetes?

Official documents discuss potential drug-drug interactions with medicines used for common chronic conditions, such as the class of drugs called sulfonylureas, used for diabetes. These interactions may necessitate close monitoring of blood sugar levels. The presence of a chronic condition is a factor that is typically assessed by a healthcare professional before use.


Q: Are there genetic factors that influence how Benzol works?

Regulatory documents acknowledge that clearance (how the body eliminates the drug) differs among patient groups. Specifically, officials have noted that certain patient populations, such as Asian patients, may require consideration for dose reduction due to pharmacokinetic differences, which are often influenced by genetic factors.


Q: Does Benzol affect blood pressure or heart rate?

While major regulatory bodies do not list cardiovascular effects as common, post-marketing surveillance reports have included instances of elevated blood pressure as an adverse reaction. Changes in blood pressure or heart rate are typically evaluated by a healthcare professional.


Q: Is Benzol the same type of medicine as [similar common drug name]?

Benzol is classified by health authorities as a Proton Pump Inhibitor (PPI). Medicines with the same pharmacological classification, such as lansoprazole, esomeprazole, or pantoprazole, are considered the same type of medicine. They share a similar chemical structure and operate by the same mechanism of action (blocking the proton pump) to reduce stomach acid.


Q: Does Benzol have any reported interactions with alcohol?

Regulatory studies indicate that alcohol does not significantly interact with the way the body processes Benzol, meaning it does not typically change the drug's levels in the blood. However, alcohol consumption itself may independently worsen the acid-related symptoms that Benzol is being used to treat.


Q: Does Benzol interact with vitamins or herbal supplements?

Yes, regulatory documents note that Benzol can interact with certain non-prescription substances. Specifically, it can reduce the absorption of certain nutrients, leading to long-term risks of Vitamin B12 and magnesium deficiency. Additionally, substances like the herbal product St. John's Wort are noted for potentially affecting Benzol's drug levels.


Q: Can people with kidney conditions use Benzol?

Official guidance permits the use of Benzol in patients with renal impairment (kidney function issues), but it advises caution. Regulatory warnings also note that a serious kidney condition called Acute Tubulointerstitial Nephritis (AIN) has been reported as a rare adverse reaction that can occur during treatment with the drug.


Q: Is it known if Benzol passes into breast milk?

Regulatory documentation states that limited data suggest that omeprazole may be present in human milk. This observation informs the official guidance that restricts use and requires consideration of discontinuing the medicine or discontinuing nursing.

How should Benzol be stored and disposed of?

The storage and disposal of Benzol (omeprazole) must adhere strictly to regulatory requirements to preserve the integrity of its delayed-release formulation. The product must be stored at controlled room temperature, typically 20 C to 25 C, and protected from moisture.

Storage Conditions

Requirement Rule
Temperature Store at controlled room temperature; do not freeze [Source 3.1].
Protection Keep in the original container and protect from moisture [Source 3.2].
Safety Keep out of the sight and reach of children [Source 3.2].

Disposal

Unused or expired Benzol must not be thrown into household trash or poured down a drain [Source 3.3]. Disposal must follow the official procedures established by the local regulatory authority or pharmacy take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Benzol found in:

A-Z Index: